Pharma News

Indian Government to launch own brand of generics

Home/Pharma News | Posted 06/03/2015

Not happy with its current control over the price of drugs in the country, the Indian Government has announced plans to launch its own brand of low cost generics.

Canada clamps down on companies failing to post drug shortage information

Home/Pharma News | Posted 27/02/2015

The Canadian Government has made it mandatory for drug companies to report actual and anticipated drug shortages. A voluntary system that had been in place was not working well enough, said the country’s Health Minister, Rona Ambrose.

Pfizer sets to lead biosimilars and generics markets

Home/Pharma News | Posted 20/02/2015

Pharma giant Pfizer has announced it is to buy injectable generics specialist and biosimilars maker Hospira for US$17 billion. The products acquired in the deal will be integrated into Pfizer’s generics unit, Global Established Pharmaceutical (GEP).

Mylan on track to acquire Abbott generics and expand role in women’s health

Home/Pharma News | Posted 13/02/2015

The European Commission (EC) has approved Mylan’s acquisition of Abbott Laboratories' Non-US Developed Markets Specialty and Branded Generics Business (Abbott EPD-DM), subject to conditions. US-based generics manufacturer Mylan will have to sell off a number of its businesses in France, Germany, Ireland, Italy and UK in order to satisfy European Union merger regulations.

Actavis to buy UK generics maker Auden McKenzie

Home/Pharma News | Posted 06/02/2015

US generics maker Actavis announced on 26 January 2015 that it had agreed to buy UK generics maker Auden McKenzie. The deal will propel Actavis into the top position in the UK for generics suppliers, placing it in third position in the UK overall.

Amgen’s approach in the biosimilars market

Home/Pharma News | Posted 23/01/2015

Biotech giant Amgen now has a biosimilars programme that includes nine different molecules [1]. A representative from Amgen has spoken to GaBI about the company’s venture into biosimilars [2].

Cipla makes deal with Serum Institute for vaccines in Europe

Home/Pharma News | Posted 05/12/2014

India-based generics maker Cipla announced on 20 November 2014 that it had signed a deal with the Serum Institute of India (Serum Institute) to distribute vaccines in Europe.

Actavis buys Allergan and joins pharma top 10

Home/Pharma News | Posted 28/11/2014

On 17 November 2014, US generics maker Actavis announced that the company had made a deal to acquire botox-maker Allergan for US$66 billion.

Xbrane signs biosimilar optimization deal with Indian pharma firm

Home/Pharma News | Posted 14/11/2014

Swedish biotech company Xbrane Bioscience (Xbrane) has signed an agreement with a global Indian pharmaceutical company to assist them in developing an optimized production system for a specific biosimilar that will be marketed worldwide. The aim is to help the client reduce production costs in order to gain a competitive advantage in the biosimilar market.